Category: Approval/Launch Region: North America · United States Company: Pfizer Inc

US FDA grants EUA to Pfizer and BioNTechs Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine booster in children 5 through 11 years of age

US FDA grants EUA to Pfizer and BioNTechs Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine booster in children 5 through 11 years of age
Pfizer Inc. and BioNTech SE announced that the US Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a 10-

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!